Literature DB >> 1764363

Regional delivery of microspheres to liver metastases: the effects of particle size and concentration on intrahepatic distribution.

J H Anderson1, W J Angerson, N Willmott, D J Kerr, C S McArdle, T G Cooke.   

Abstract

There is increasing interest in the use of microspheres, loaded with chemotherapeutic agents, for regional therapy to hepatic metastases. It is necessary to deliver these particles predominately to tumour rather than to normal liver. This study investigates factors influencing the distribution of regionally injected microspheres. Discreet tumour was induced in rats by subcapsular hepatic inoculations of HSN cells. At 20 days, 12.5 microns, 25 microns or 40 microns diameter, radiolabelled albumin microspheres were administered, in various concentrations, via the gastroduodenal artery. Tumour to normal liver microsphere distribution ratios were determined and median values ranged from 0.1 (0.2 mg ml-1 12.5 microns microspheres) to 1.8 (20 mg ml 40 microns microspheres). Concentrated suspensions (20 mg ml-1) of large microspheres (40 microns) produced the most favourable tumour to normal liver distribution ratios. These results not only have implications for the therapeutic administration of microspheres but also for their use in blood-flow studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764363      PMCID: PMC1977859          DOI: 10.1038/bjc.1991.459

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats.

Authors:  N Willmott; Y Chen; J Goldberg; C Mcardle; A T Florence
Journal:  J Pharm Pharmacol       Date:  1989-07       Impact factor: 3.765

2.  Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapy.

Authors:  C S McArdle; H Lewi; D Hansell; D J Kerr; J McKillop; N Willmott
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

3.  Reference sample method for cardiac output and regional blood flow determinations in the rat.

Authors:  A B Malik; J E Kaplan; T M Saba
Journal:  J Appl Physiol       Date:  1976-03       Impact factor: 3.531

4.  Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres.

Authors:  D Civalleri; G Scopinaro; N Balletto; F Claudiani; F De Cian; F DeCian; G Camerini; M DePaoli; U Bonalumi
Journal:  Br J Surg       Date:  1989-07       Impact factor: 6.939

5.  Radionuclide angiography to predict patient response to hepatic artery chemotherapy.

Authors:  W D Kaplan; W D Ensminger; S E Come; E H Smith; C J D'Orsi; D C Levin; R W Takvorian; G D Steele
Journal:  Cancer Treat Rep       Date:  1980

6.  Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats.

Authors:  D M Hemingway; T G Cooke; S J Grime; D M Nott; S A Jenkins
Journal:  Br J Surg       Date:  1991-03       Impact factor: 6.939

7.  Distribution of different sized microspheres in experimental hepatic tumours.

Authors:  V M Meade; M A Burton; B N Gray; G W Self
Journal:  Eur J Cancer Clin Oncol       Date:  1987-01

8.  Predicting tumor response in patients with colorectal hepatic metastases.

Authors:  J M Daly; J Butler; N Kemeny; S D Yeh; J A Ridge; J Botet; J R Bading; J J DeCosse; R S Benua
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

9.  Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II.

Authors:  J A Goldberg; M S Bradnam; D J Kerr; J H McKillop; R G Bessent; C S McArdle; N Willmott; W D George
Journal:  Nucl Med Commun       Date:  1987-12       Impact factor: 1.690

10.  Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat.

Authors:  N Willmott; J Cummings; J F Stuart; A T Florence
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

View more
  7 in total

1.  Activity of doxorubicin covalently bound to a novel human serum albumin microcapsule.

Authors:  M Eatock; N Church; R Harris; W Angerson; C McArdle; R French; C Twelves
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 2.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

Review 3.  Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.

Authors:  T Taguchi
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

Review 4.  Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.

Authors:  J H Anderson; H W Warren; C S McArdle
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 5.  The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.

Authors:  Mark A Westcott; Douglas M Coldwell; David M Liu; Joseph F Zikria
Journal:  Adv Radiat Oncol       Date:  2016-08-18

6.  Is there a relationship between regional microsphere distribution and hepatic arterial blood flow?

Authors:  J H Anderson; W J Angerson; N Willmott; D J Kerr; C S McArdle; T G Cooke
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

7.  Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II.

Authors:  D M Hemingway; W J Angerson; J H Anderson; J A Goldberg; C S McArdle; T G Cooke
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.